PAUL J HASTINGS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL J HASTINGS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL J HASTINGS. PAUL J HASTINGS is a President & CEO in QLT INC/BC ($QLTI) and a Chairman & CEO in OncoMed Pharmaceuticals Inc ($OMED) and an Chief Executive Officer in OncoMed Pharmaceuticals Inc ($OMED) and a Director in PROTEON THERAPEUTICS INC ($PRTO) and a Director in Pacira Pharmaceuticals, Inc. ($PCRX) and a Director in Relypsa Inc ($RLYP) and an Chief Executive Officer in Nkarta, Inc. ($NKTX) and a See Remarks in Nkarta, Inc. ($NKTX).
Address: 887 GREAT NORTHERN WAY VANCOUVER, BRITISH COLUMBIA V5T 4T5
Companies in which PAUL J HASTINGS is an Insider
Nkarta, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Chief Executive Officer, See Remarks
Holdings: 241,600 shares
Latest Transaction: Apr 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: President & CEO
Holdings: 9,500 shares
Latest Transaction: Apr 29 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoMed Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Chairman & CEO, Chief Executive Officer
Holdings: 77,534 shares
Current Value: $634,228
Latest Transaction: Oct 12 2017
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Director
Holdings: 6,552 shares
Current Value: $273,546
Latest Transaction: Jun 11 2021
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL J HASTINGS: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2018
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL J HASTINGS: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL J HASTINGS
Sentiment: All, NKTX, NVLN, OMED, PCRX, TARA, RLYP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 60.96 | 7,626 | 464,881 | 7,626 | |
| Jun 11 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,066 | 0 | 6,552 | 5.5 K to 6.6 K (+19.43 %) |
| Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Off ... | Sell | S | 32.21 | 3,130 | 100,817 | 236,061 | 239.2 K to 236.1 K (-1.31 %) |
| Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Off ... | Sell | S | 31.24 | 2,409 | 75,257 | 239,191 | 241.6 K to 239.2 K (-1.00 %) |
| Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Off ... | Sell | S | 30.23 | 11,461 | 346,466 | 241,600 | 253.1 K to 241.6 K (-4.53 %) |
| Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | M | 13.98 | 3,000 | 41,940 | 0 | |
| Mar 09 2021 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 65.88 | 3,000 | 197,640 | 6,116 | 9.1 K to 6.1 K (-32.91 %) |